Carac (Valeant Pharmaceuticals North America LLC)
Welcome to the PulseAid listing for the Carac drug offered from Valeant Pharmaceuticals North America LLC. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Valeant Pharmaceuticals North America LLC |
| NON-PROPRIETARY NAME: | fluorouracil |
| SUBSTANCE NAME: | FLUOROURACIL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-06-28 |
| END MARKETING DATE: | 0000-00-00 |
Carac HUMAN PRESCRIPTION DRUG Details:
| Item Description | Carac from Valeant Pharmaceuticals North America LLC |
| LABELER NAME: | Valeant Pharmaceuticals North America LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/g) |
| START MARKETING DATE: | 2013-06-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0187-5200_fc805fee-4a6a-4807-91cc-dc450887cb37 |
| PRODUCT NDC: | 0187-5200 |
| APPLICATION NUMBER: | NDA020985 |
Other FLUOROURACIL Pharmaceutical Manufacturers / Labelers:
